By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Rosetta Genomics today announced a definitive agreement with investors for the purchase of an aggregate of $6 million in securities in concurrent private placement and registered direct offerings.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.